- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03336710
Perspective on Thoughts and Feelings as a Predictor of Psychological Well-being in Daily Life, in a Community Sample
Decentering in Daily Life: Underlying Mechanisms and Impact on Well-Being
This project examines the psychological construct of decentering - a mindfulness-related construct marked by an observer perspective on one's ongoing mental processes. Specifically, this project seeks to explore the extent to which decentering modulates the relationship between people's affective states and their momentary mental health and well-being, and to test the psychological processes by which decentering might exert these effects. This study includes a baseline assessment followed by a 7-day study completed from home where participants respond to brief surveys about their current experiences six times per day (i.e., an Ecological Momentary Assessment [EMA] design).
The investigators hypothesize that decentering moderates the association of extreme affect with related symptoms (i.e., elevated negative affect with depression and anxiety; elevated positive affect with mania, narcissism, and histrionic traits) and well-being, such that the association is attenuated at high levels of decentering. This will be examined using the EMA data, analyzing between-person levels (i.e., trait) as well as momentary within-person processes (i.e., concurrent and prospective states).
Further, the investigators predict that broadened attentional focus and improved self-regulation are mechanisms that contribute to the beneficial effects of decentering in daily life. This hypothesis will be examined in two ways:
- as individual differences, wherein greater self-regulatory abilities (e.g., higher heart rate variability) and less attentional biases towards emotional stimuli mediate the association between trait decentering and subsequent daily well-being/symptoms, and
- as within-person momentary levels, wherein broader attentional processes and greater self-regulation in daily life mediate the concurrent and prospective association between momentary decentering and well-being/symptoms.
Note that the study uses a multimodal assessment of each of the proposed processes. For attentional processes, a variety of parameters extracted from an emotional eye tracking paradigm will be examined. For self-regulatory abilities, assessments will include self-report, physiological (heart rate variability), and behavioral ("go / no-go" task) measures of such abilities.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14260
- University at Buffalo, Department of psychology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- age 18-65, fluency in English
Exclusion Criteria:
- current cognitive impairments (i.e., intellectual disability, dementia, current psychotic symptoms) that preclude giving informed consent and accurately answering study questions
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Primary sample
Community sample of adults (18-65) from the greater Buffalo, NY region, oversampling people who are seeking mental health treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Momentary psychological distress
Time Frame: 6 x daily for 7 days following the baseline assessment
|
2 items (developed new for this study) assessing the presence and impact of idiographic symptoms identified at baseline, and 4 items assessing dysphoria adapted from the Inventory of Depression and Anxiety Symptoms (IDAS)
|
6 x daily for 7 days following the baseline assessment
|
Momentary eudaimonic well-being
Time Frame: 6 x daily for 7 days following the baseline assessment
|
2 items assessing eudaimonic well-being adapted from Breines et al. (2008) and Lambert et al. (2013)
|
6 x daily for 7 days following the baseline assessment
|
Momentary hedonic well-being (state positive and negative affect)
Time Frame: 6 x daily for 7 days following the baseline assessment
|
8 items assessing hedonic well-being (positive and negative affect), taken from the Positive and Negative Affect Schedule (PANAS).
|
6 x daily for 7 days following the baseline assessment
|
State Decentering
Time Frame: 6 x daily for 7 days following the baseline assessment
|
4 items assessing current decentering, adapted from Fresco et al. (2007), Gillanders et al. (2014), and Shoham et al. (2017)
|
6 x daily for 7 days following the baseline assessment
|
Trait Decentering: Experiences Questionnaire
Time Frame: Baseline session only
|
Experiences Questionnaire is a trait measure of decentering, which assesses the Observer Perspective aspect of decentering.
From Fresco et al., (2007)
|
Baseline session only
|
Trait decentering: Valence free decentering measure
Time Frame: Baseline session only
|
This is an in-development measure of decentering that measures the construct of decentering without explicitly referring to negative thoughts and feelings.
|
Baseline session only
|
Trait decentering: Cognitive Fusion Questionnaire
Time Frame: Baseline session only
|
The Cognitive Fusion Questionnaire is a decentering measure that assesses the Reduced Struggle with Inner Experiences aspect of decentering.
From Gillanders et al., (2014).
|
Baseline session only
|
Trait decentering: Toronto Mindfulness Scale-Decentering Subscale
Time Frame: Baseline session only
|
The Toronto Mindfulness Scale-Decentering subscale is a decentering measure that assesses the Observer Perspective aspect of decentering.
From Davis, Lau, & Cairns (2009).
|
Baseline session only
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-reported momentary self-regulation
Time Frame: 6 x daily for 7 days following the baseline assessment
|
3 questions assessing current perceived willpower & mental exhaustion, adapted from Davisson (2013) and Milyavskaya & Inzlicht (2017).
|
6 x daily for 7 days following the baseline assessment
|
Self-reported momentary attentional focus
Time Frame: 6 x daily for 7 days following the baseline assessment
|
4 attentional emotion regulation items (distraction, positive rumination, negative rumination, and reappraisal) adapted from Brans et al. (2013), Feldman et al. (2008), and Nolen-Hoeksema & Morrow (1991)
|
6 x daily for 7 days following the baseline assessment
|
Baseline self-regulation: Go/no-go task
Time Frame: Baseline session only
|
Go/no-go task asks people to respond to a large number of "go" trials (80%) and a smaller number of "no go" trials.
The ability to inhibit the dominant "go" response is seen as an operative measure of self-regulatory abilities, consequently the number of "no go" signals responded to is one measure of self-regulatory abilities.
|
Baseline session only
|
Baseline self-regulation: Resting heart rate variability
Time Frame: Baseline session only
|
Assessed with a Polar V800 athletic watch during a 5-minute vanilla baseline and a 5-minute paced breathing task.
|
Baseline session only
|
Baseline self-regulation: Self-Control Scale (short form)
Time Frame: Baseline session only
|
A self-report measure of people's perceived self-control abilities and outcomes, developed by Tangney, Baumeister, & Boone (2004).
|
Baseline session only
|
Baseline attentional breadth: Emotional eye-tracking paradigm
Time Frame: Baseline session only
|
Participants will view a series of emotionally expressive versus neutral faces, and the fixation time and number of fixations towards emotionally evocative (angry, sad, happy) faces will serve as indicators of attentional bias
|
Baseline session only
|
Baseline attentional breadth: Thought Control Questionnaire
Time Frame: Baseline session only
|
Self-report measure corresponding to various emotion regulation strategies (distraction and reappriasal)
|
Baseline session only
|
Baseline attentional breadth: Responses to Positive Affect Scale
Time Frame: Baseline session only
|
Self-report measure corresponding to various emotion regulation strategies (positive rumination)
|
Baseline session only
|
Baseline attentional breadth: Ruminative Responses Scale
Time Frame: Baseline session only
|
Self-report measure corresponding to various emotion regulation strategies (negative rumination)
|
Baseline session only
|
Collaborators and Investigators
Investigators
- Principal Investigator: Kristin Gainey, Ph.D., University at Buffalo
- Principal Investigator: Kenneth G DeMarree, Ph.D., University at Buffalo
Publications and helpful links
General Publications
- Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063.
- Gillanders DT, Bolderston H, Bond FW, Dempster M, Flaxman PE, Campbell L, Kerr S, Tansey L, Noel P, Ferenbach C, Masley S, Roach L, Lloyd J, May L, Clarke S, Remington B. The development and initial validation of the cognitive fusion questionnaire. Behav Ther. 2014 Jan;45(1):83-101. doi: 10.1016/j.beth.2013.09.001. Epub 2013 Sep 18.
- Tangney JP, Baumeister RF, Boone AL. High self-control predicts good adjustment, less pathology, better grades, and interpersonal success. J Pers. 2004 Apr;72(2):271-324. doi: 10.1111/j.0022-3506.2004.00263.x.
- Watson D, O'Hara MW, Simms LJ, Kotov R, Chmielewski M, McDade-Montez EA, Gamez W, Stuart S. Development and validation of the Inventory of Depression and Anxiety Symptoms (IDAS). Psychol Assess. 2007 Sep;19(3):253-68. doi: 10.1037/1040-3590.19.3.253.
- Gross JJ, John OP. Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being. J Pers Soc Psychol. 2003 Aug;85(2):348-62. doi: 10.1037/0022-3514.85.2.348.
- Fresco DM, Moore MT, van Dulmen MH, Segal ZV, Ma SH, Teasdale JD, Williams JM. Initial psychometric properties of the experiences questionnaire: validation of a self-report measure of decentering. Behav Ther. 2007 Sep;38(3):234-46. doi: 10.1016/j.beth.2006.08.003. Epub 2007 Apr 24.
- Naragon-Gainey K, DeMarree KG. Structure and validity of measures of decentering and defusion. Psychol Assess. 2017 Jul;29(7):935-954. doi: 10.1037/pas0000405. Epub 2016 Oct 31.
- Bernstein A, Hadash Y, Lichtash Y, Tanay G, Shepherd K, Fresco DM. Decentering and Related Constructs: A Critical Review and Metacognitive Processes Model. Perspect Psychol Sci. 2015 Sep;10(5):599-617. doi: 10.1177/1745691615594577.
- Shoham A, Goldstein P, Oren R, Spivak D, Bernstein A. Decentering in the process of cultivating mindfulness: An experience-sampling study in time and context. J Consult Clin Psychol. 2017 Feb;85(2):123-134. doi: 10.1037/ccp0000154.
- Naragon-Gainey K, DeMarree KG. Decentering attentuates the associations of negative affect and positive affect with psychopathology. Clinical Psychological Science. Epub 2017 Aug 11.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1R21AT009470-01 (U.S. NIH Grant/Contract)
- R21AT009470 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Health
-
Chinese University of Hong KongNot yet recruitingMental Health Wellness 1 | Mental Well-being | Mental Health Issue | Precision Mental HealthHong Kong
-
King's College LondonCompletedMental Health Wellness 1 | Mental Health IssueUnited Kingdom
-
VA Office of Research and DevelopmentCompletedMental Health | Veterans Health | Rural HealthUnited States
-
Chapin Hall at the University of ChicagoUniversity of ConnecticutCompletedMental Health | Physical Health
-
National Taiwan Normal UniversityCompletedMental Health | Physical HealthTaiwan
-
Virginia Commonwealth UniversityCompletedMental Health DisordersUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMental Health DisordersCongo
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedMental Health DisordersNorway
-
University of WarwickKing's College London; KU Leuven; University Hospital, Montpellier; Erasmus Medical... and other collaboratorsUnknownMental Health Disorder | Mental Health ImpairmentIreland, United Kingdom, Netherlands, Germany, Belgium, Croatia, France, Italy
-
York UniversityCanadian Institutes of Health Research (CIHR); North York General HospitalCompletedMental Health DisordersCanada